FDA.reportPublic FDA data

Otezla XR 75 MG 24HR Extended Release Oral Tablet

RxCUI
2723452
RxNorm name
Otezla XR 75 MG 24HR Extended Release Oral Tablet
Display name
Otezla XR 75 MG 24HR Extended Release Oral Tablet
Full name
Otezla XR 75 MG 24HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OtezlaAPREMILASTAmgen, Incf6b1f516-4972-4d82-bced-113e47b41cc52025-12-23Warnings, Adverse reactionsExact identifier
rxcui: 2723452

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f6b1f516-4972-4d82-bced-113e47b41cc5Otezla XR 75 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla] [SBD] · Otezla XR 75 MG 24HR Extended Release Oral Tablet [SY]334These highlights do not include all the information needed to use OTEZLA/OTEZLA XR safely and effectively. See full prescribing information for OTEZLA/OTEZLA XR. OTEZLA ® (apremilast) tablets, for oral use OTEZLA XR™ (apremilast) extended-release tablets, for oral use Initial U.S. Approval: 201420251223